Trial Profile

European phase II trial of an encapsulated cell therapy product [NovaCaps] for advanced, inoperable pancreatic cancer

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 15 Oct 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Microencapsulated CYP2B1-expressing cells+ifosfamide PharmaCyte Biotech (Primary) ; Ifosfamide
Indications Pancreatic cancer
Focus Therapeutic Use

Most Recent Events

14 Aug 2014 Results published in a Nuvilex media release
27 Sep 2012 Results will be presented at the International Society for Cell and Gene Therapy (ISCGT) in early October 2012.
27 Sep 2012 Status changed from planning to active, no longer recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com